The Global High Intensity Focused Ultrasound Market size is expected to reach $1.9 billion by 2031, rising at a market growth of 7.1% CAGR during the forecast period.
HIFU is a uterus-preserving procedure, which is important for patients who wish to retain their uterus for future pregnancies. This aspect of HIFU makes it a preferred option for women who want to avoid hysterectomy, which involves the removal of the uterus. Thus, the uterine fibroids segment attained 19% revenue share in the market in 2023. HIFU is typically performed as an outpatient, meaning patients do not need to stay overnight in a hospital. This convenience adds to its appeal and makes it a more accessible option for many.
Chronic diseases like cancer are becoming more prevalent worldwide, with increasing rates of prostate cancer, liver cancer, and other solid tumours. HIFU has been established as an effective non-invasive treatment option for certain types of cancer, such as prostate cancer, where it is used to destroy cancerous tissues without the need for surgery. As per the WHO, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. The most common cancers are breast, lung, colon and rectum and prostate cancers. Hence, the increasing prevalence of chronic diseases drives the market’s growth.
Patients increasingly seek less invasive treatments with fewer risks and shorter recovery times. Traditional surgical procedures often involve incisions, anaesthesia, and extended hospital stays, which can be daunting for many patients. In contrast, HIFU offers a non-invasive alternative using focused ultrasound waves to target and treat tissues without incisions. This appeal of a less invasive treatment option drives patient preference toward HIFU, increasing its adoption. In conclusion, the growing preference for non-invasive procedures propels the market’s growth.
However, HIFU equipment is sophisticated and technologically advanced, which results in high initial capital costs. The expense of purchasing, installing, and setting up HIFU systems can be prohibitive, particularly for smaller healthcare facilities or those in developing regions. This high upfront investment can deter healthcare providers from adopting HIFU technology. The maintenance of HIFU equipment requires specialized service and regular upgrades to ensure optimal performance. These ongoing costs add to the total expenditure of operating HIFU systems. In conclusion, the high cost of equipment and procedures is hampering the market’s growth.
HIFU is a uterus-preserving procedure, which is important for patients who wish to retain their uterus for future pregnancies. This aspect of HIFU makes it a preferred option for women who want to avoid hysterectomy, which involves the removal of the uterus. Thus, the uterine fibroids segment attained 19% revenue share in the market in 2023. HIFU is typically performed as an outpatient, meaning patients do not need to stay overnight in a hospital. This convenience adds to its appeal and makes it a more accessible option for many.
Chronic diseases like cancer are becoming more prevalent worldwide, with increasing rates of prostate cancer, liver cancer, and other solid tumours. HIFU has been established as an effective non-invasive treatment option for certain types of cancer, such as prostate cancer, where it is used to destroy cancerous tissues without the need for surgery. As per the WHO, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. The most common cancers are breast, lung, colon and rectum and prostate cancers. Hence, the increasing prevalence of chronic diseases drives the market’s growth.
Patients increasingly seek less invasive treatments with fewer risks and shorter recovery times. Traditional surgical procedures often involve incisions, anaesthesia, and extended hospital stays, which can be daunting for many patients. In contrast, HIFU offers a non-invasive alternative using focused ultrasound waves to target and treat tissues without incisions. This appeal of a less invasive treatment option drives patient preference toward HIFU, increasing its adoption. In conclusion, the growing preference for non-invasive procedures propels the market’s growth.
However, HIFU equipment is sophisticated and technologically advanced, which results in high initial capital costs. The expense of purchasing, installing, and setting up HIFU systems can be prohibitive, particularly for smaller healthcare facilities or those in developing regions. This high upfront investment can deter healthcare providers from adopting HIFU technology. The maintenance of HIFU equipment requires specialized service and regular upgrades to ensure optimal performance. These ongoing costs add to the total expenditure of operating HIFU systems. In conclusion, the high cost of equipment and procedures is hampering the market’s growth.
Driving and Restraining Factors
Drivers
- Growing Preference for Non-Invasive Procedures
- Expansion of Focused Ultrasound Centres
- Increasing Prevalence of Chronic Diseases
Restraints
- High Cost of Equipment and Procedures
- Limited Clinical Data for Certain Applications
Opportunities
- Expansion Into Veterinary Medicine
- Development Of Portable HIFU Devices
Challenges
- Increasing Competition from Alternative Treatments
- Patient Concerns Over Side Effects
Application Outlook
Based on application, the market is divided into uterine fibroids, prostate cancer, essential tremor, dermatology, breast cancer, glaucoma, back pain, facetogenic, and others. In 2023, the dermatology segment garnered 20% revenue share in the market. HIFU is effective for non-surgical face lifting and tightening, which addresses common dermatological concerns such as sagging skin and wrinkles. It stimulates collagen production, leading to skin tightening and rejuvenation, which is particularly appealing in the cosmetic dermatology market.
End Use Outlook
By end use, the market is divided into hospitals, imaging centers, and others. The imaging centres segment procured 33% revenue share in the market in 2023. Imaging centres specialize in diagnostic imaging and interventional procedures, making them well-suited for performing HIFU. The expertise and focus on imaging in these centres enhance the quality of HIFU treatments and ensure accurate targeting. Imaging centres often provide a more accessible and convenient location for patients than hospitals.Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed 38% revenue share in the market in 2023. North America, particularly the United States and Canada, has a well-developed healthcare infrastructure with access to cutting-edge medical technologies and facilities. This infrastructure supports the adoption and use of advanced treatments like HIFU. The prevalence of conditions that HIFU can treat, such as uterine fibroids, prostate cancer, and certain types of tumours, is relatively high in North America. This drives the demand for effective treatment options.List of Key Companies Profiled
- EDAP TMS S.A
- Sonablate Corp.
- Verasonics, Inc.
- ALPINION MEDICAL SYSTEMS Co., Ltd.
- Theraclion
- Lynton Lasers Ltd
- ULTRAISER
- PROFOUND MEDICAL CORP.
Market Report Segmentation
By End Use
- Hospital
- Imaging Centers
- Others
By Application
- Dermatology
- Uterine Fibroids
- Prostate Cancer
- Essential Tremor
- Breast Cancer
- Glaucoma
- Backpain, Facetogenic
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Australia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Global High Intensity Focused Ultrasound Market by End Use
Chapter 5. Global High Intensity Focused Ultrasound Market by Application
Chapter 6. Global High Intensity Focused Ultrasound Market by Region
Chapter 7. Company Profiles
Companies Mentioned
- EDAP TMS S.A
- Sonablate Corp.
- Verasonics, Inc.
- ALPINION MEDICAL SYSTEMS Co., Ltd.
- Theraclion
- Lynton Lasers Ltd
- ULTRAISER
- PROFOUND MEDICAL CORP.
Methodology
LOADING...
